TRVI logo

Trevi Therapeutics (TRVI)

Profile

Full Name

Trevi Therapeutics, Inc.

Ticker Symbol

TRVI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 7, 2019

Indexes

Not included

Website

http://www.trevitherapeutics.com

Employees

31

Key Details

Price

$5.62(-0.71%)

Market cap

$571.81M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.47(-62.07% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.62
    TRVI price is $5.62

    30-Day Relative Volume

    1.06
    TRVI 30-day relative volume is 1.06

    Price Performance

    Price Most recent change

    -0.71%
    TRVI price was down -0.71% on Jun 27, 2025

    Price YTD change

    +36.41%
    TRVI price is up +36.41% since January 1st

    Price 1-year change

    +91.16%
    TRVI price is up +91.16% year-on-year

    Price 3-year change

    +181%
    TRVI price is up +181% over the past 3 years

    Price Range

    Price All-time high

    $10.62
    TRVI price is currently -47.08% below its historical high of $10.62

    Price 3-year low

    $0.97
    TRVI price is currently +479.38% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $571.81M
    TRVI market capitalization is $571.81 million

    Market cap 3-year change

    +639.04%
    TRVI market capitalization is up +639.04% over the past 3 years

    Market cap All-time high

    $718.32M
    TRVI market capitalization is currently -20.40% below its historical high of $718.32 million

    Market cap sector rank

    69.64%
    TRVI market capitalization is higher than 69.64% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +44.45%
    TRVI shares outstanding is up +44.45% year-on-year

    Shares Outstanding 3-Year Change

    +163%
    TRVI shares outstanding is up +163% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.44
    TRVI beta is 0.44

    200-day SMA

    $4.61
    TRVI price is currently +22.04% above its 200-day simple moving average

    50-day SMA

    $6.32
    TRVI price is currently -11.14% below its 50-day simple moving average

    RSI

    38.03
    TRVI 14-day relative strength index is 38.03

    Volume

    1.06
    TRVI 30-day relative volume is 1.06

    ATR

    $0.33
    TRVI average true range is $0.33

    10-day Historical Volatility

    33.72%
    TRVI 10-day historical volatility is 33.72%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    TRVI annual revenue value is unknown

    Revenue Analysts estimate

    -
    TRVI annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    TRVI annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    TRVI annual revenue is unknown

    EPS

    EPS

    -$0.47
    TRVI annual earnings per share is -$0.47

    EPS Analysts estimate

    -$0.43
    TRVI annual earnings per share is currently +8.95% higher than the consensus analysts' forecast

    EPS 1-year change

    -62.07%
    TRVI annual earnings per share is down -62.07% year-on-year

    EPS Sector rank

    69.11%
    TRVI annual earnings per share is higher than 69.11% of companies in Healthcare sector

    Profit

    Gross profit

    -
    TRVI annual gross profit value is unknown

    Gross margin

    -
    TRVI annual gross profit margin value is unknown

    Operating profit

    -$51.52M
    TRVI annual operating income is -$51.52 million

    Operating margin

    -
    TRVI annual operating profit margin value is unknown

    Net income

    -$47.91M
    TRVI annual net profit is -$47.91 million

    Net margin

    -
    TRVI annual net profit margin value is unknown

    Expenses

    Total expenses

    $51.52M
    TRVI annual total expenses is $51.52 million

    Operating expenses

    $51.52M
    TRVI annual total operating expenses is $51.52 million

    Cost of goods sold

    -
    TRVI annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $12.15M
    TRVI annual SGA is $12.15 million

    Depreciation and amortization

    $147.00K
    TRVI annual depreciation & amortization is $147.00 thousand

    Interest expense

    $4000.00
    TRVI annual interest expense is $4000.00

    Income tax

    -$30.00K
    TRVI annual income tax is -$30.00 thousand

    EBIT & EBITDA

    EBIT

    -$47.94M
    TRVI annual earnings before interest & taxes is -$47.94 million

    EBITDA

    -$47.79M
    TRVI annual EBITDA is -$47.79 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $110.90M
    TRVI annual total assets is $110.90 million

    Non current assets

    $1.47M
    TRVI annual long term assets is $1.47 million

    Current assets

    $109.43M
    TRVI annual total current assets is $109.43 million

    Cash and cash equivalents

    $34.10M
    TRVI annual cash & cash equivalents is $34.10 million

    Accounts receivable

    -
    TRVI annual accounts receivable value is unknown

    Inventory

    -
    TRVI annual inventory value is unknown

    Liabilities

    Total liabilities

    $11.26M
    TRVI annual total liabilities is $11.26 million

    Long term liabilities

    $747.00K
    TRVI annual total long term liabilities is $747.00 thousand

    Current liabilities

    $10.51M
    TRVI annual total current liabilities is $10.51 million

    Accounts payable

    $3.41M
    TRVI annual accounts payable is $3.41 million

    Debt

    Total debt

    $1.03M
    TRVI annual total debt is $1.03 million

    Total debt 1-year change

    -22.87%
    TRVI annual total debt is down -22.87% year-on-year

    Long term debt

    $747.00K
    TRVI annual long term debt is $747.00 thousand

    Short term debt

    $285.00K
    TRVI annual short term debt is $285.00 thousand

    Equity & Capital

    Shareholders equity

    $99.64M
    TRVI annual stockholders equity is $99.64 million

    Book value

    $99.64M
    TRVI annual book value is $99.64 million

    Retained earnings

    -$287.05M
    TRVI annual retained earnings is -$287.05 million

    Working capital

    $98.92M
    TRVI annual working capital is $98.92 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$38.26M
    TRVI annual cash flow from operations is -$38.26 million

    Cash from operations 1-year change

    -20.64%
    TRVI annual cash flow from operations is down -20.64% year-on-year

    Cash from investing

    -$21.53M
    TRVI annual cash flow from investing activities is -$21.53 million

    Cash from investing 1-year change

    -136.23%
    TRVI annual cash flow from investing activities is down -136.23% year-on-year

    Cash from financing

    $61.48M
    TRVI annual cash flow from financing activities is $61.48 million

    Cash from financing 1-year change

    +877.29%
    TRVI annual cash flow from financing activities is up +877.29% year-on-year

    CAPEX

    CAPEX

    -
    TRVI annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    TRVI annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$38.29M
    TRVI annual free cash flow is -$38.29 million

    Free cash flow 1-year change

    -20.23%
    TRVI annual free cash flow is down -20.23% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    TRVI annual gross profit margin value is unknown

    Operating margin

    -
    TRVI annual operating profit margin value is unknown

    Net margin

    -
    TRVI annual net profit margin value is unknown

    ROA & ROE

    ROA

    -43.20%
    TRVI annual return on assets is -43.20%

    ROE

    -48.08%
    TRVI annual return on equity is -48.08%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TRVI price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TRVI price to earnings ratio is unknown

    PB Ratio

    PB ratio

    5.75
    TRVI price to book ratio is 5.75

    PB ratio Sector rank

    83.05%
    TRVI price to book ratio is higher than 83.05% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    TRVI price to sales ratio value is unknown

    PS ratio Sector rank

    -
    TRVI price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $553.39M
    TRVI enterprise value is $553.39 million

    Enterprise value Sector rank

    68.76%
    TRVI enterprise value is higher than 68.76% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -11.72
    TRVI EV/EBITDA is -11.72

    EV/EBITDA Sector rank

    11.92%
    TRVI EV/EBITDA is higher than 11.92% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.41
    TRVI annual current ratio is 10.41

    Quick ratio

    -
    TRVI annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.01
    TRVI annual debt to equity ratio is 0.01

    Interest coverage ratio

    -11.98K
    TRVI annual interest coverage ratio is -11.98 thousand

    Risk & Stability

    Piotroski F-Score

    -
    TRVI piotroski f-score value is unknown

    Altman Z-Score

    -
    TRVI altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 2, 25 D. Boral Capital
    Buy
    May 28, 25 HC Wainwright & Co.
    Buy
    May 20, 25 Needham
    Buy
    Apr 8, 25 Needham
    Buy
    Mar 19, 25 Needham
    Buy
    Mar 19, 25 HC Wainwright & Co.
    Buy
    Mar 19, 25 D. Boral Capital
    Buy
    Mar 19, 25 B. Riley Securities
    Buy
    Mar 11, 25 Oppenheimer
    Outperform
    Mar 10, 25 Raymond James
    Strong Buy

    Institutional Ownership

    Screeners with TRVI included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    NASDAQ Listed Companies
    • What is the ticker symbol for Trevi Therapeutics?
    • Does Trevi Therapeutics pay dividends?
    • What sector is Trevi Therapeutics in?
    • What industry is Trevi Therapeutics in?
    • What country is Trevi Therapeutics based in?
    • When did Trevi Therapeutics go public?
    • Is Trevi Therapeutics in the S&P 500?
    • Is Trevi Therapeutics in the NASDAQ 100?
    • Is Trevi Therapeutics in the Dow Jones?
    • When was Trevi Therapeutics's last earnings report?
    • When does Trevi Therapeutics report earnings?
    • Should I buy Trevi Therapeutics stock now?

    What is the ticker symbol for Trevi Therapeutics?

    The ticker symbol for Trevi Therapeutics is NASDAQ:TRVI

    Does Trevi Therapeutics pay dividends?

    No, Trevi Therapeutics does not pay dividends

    What sector is Trevi Therapeutics in?

    Trevi Therapeutics is in the Healthcare sector

    What industry is Trevi Therapeutics in?

    Trevi Therapeutics is in the Biotechnology industry

    What country is Trevi Therapeutics based in?

    Trevi Therapeutics is headquartered in United States

    When did Trevi Therapeutics go public?

    Trevi Therapeutics's initial public offering (IPO) was on May 7, 2019

    Is Trevi Therapeutics in the S&P 500?

    No, Trevi Therapeutics is not included in the S&P 500 index

    Is Trevi Therapeutics in the NASDAQ 100?

    No, Trevi Therapeutics is not included in the NASDAQ 100 index

    Is Trevi Therapeutics in the Dow Jones?

    No, Trevi Therapeutics is not included in the Dow Jones index

    When was Trevi Therapeutics's last earnings report?

    Trevi Therapeutics's most recent earnings report was on May 8, 2025

    When does Trevi Therapeutics report earnings?

    The next expected earnings date for Trevi Therapeutics is Aug 8, 2025

    Should I buy Trevi Therapeutics stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page